Implante intravítreo de dexametasona como tratamento adjuvante em pacientes pediátricos com doença de Coats

Related authors

• Ana Maria Dorado
• Almudena De-Pablo-Cabrera
• Alicia Muñoz-Gallego
• Luis Moreno-García
• Ana Barceló-Mendiguchía
• Tejada-Palacios Pilar

Related articles

• Scleral communication between Glaucoma drainage device capsule and the suprachoroidal space simulating amelanotic choroidal melanoma
• Viscotrabeculotomy with anterior chamber irrigation versus Ahmed glaucoma valve implantation for silicone oil glaucoma in the pseudophakic eye
• Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion
• Morphofunctional evaluation of peripapillary retinoschisis associated with myopic posterior staphyloma and hyaloid traction: does it cause peripapillary vitreoretinal traction?
• Retinal vein and artery occlusion as the first manifestation of primary antiphospholipid syndrome in a pediatric patient
• Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathy
• Spontaneous closure of a macular hole in an unusually long time after primary vitrectomy
• Coats disease with retinal neovascularization under subfoveal nodule: optical coherence tomography-angiography findings before and after ranibizumab treatment
• Iridochorioretinal coloboma associated with buried optic nerve drusen: a case report
• Subfoveal perfluorocarbon liquid removal by peeling of internal limiting membrane, without retinotomy

Click here to search